Testing clonal relatedness of tumors using array comparative genomic hybridization: a statistical challenge
- PMID: 20179213
- PMCID: PMC2831112
- DOI: 10.1158/1078-0432.CCR-09-2398
Testing clonal relatedness of tumors using array comparative genomic hybridization: a statistical challenge
Abstract
In recent years several investigative groups have sought to use array technologies that characterize somatic alterations in tumors, such as array comparative genomic hybridization (ACGH), to classify pairs of tumors from the same patients as either independent primary cancers or metastases. A wide variety of strategies have been proposed. Several groups have endeavored to use hierarchical clustering for this purpose. This technique was popularized in genomics as a means of finding clusters of patients with similar gene expression patterns with a view to finding subcategories of tumors with distinct clinical characteristics. Unfortunately, this method is not well suited to the problem of classifying individual pairs of tumors as either clonal or independent. In this article we show why hierarchical clustering is unsuitable for this purpose, and why this method has the paradoxical property of producing a declining probability that clonal tumor pairs will be correctly identified as more information is accrued (i.e., more patients). We discuss alternative strategies that have been proposed, which are based on more conventional conceptual formulations for statistical testing and diagnosis, and point to the remaining challenges in constructing valid and robust techniques for this problem.
Figures




Similar articles
-
Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.Clin Cancer Res. 2009 Aug 15;15(16):5184-90. doi: 10.1158/1078-0432.CCR-09-0594. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671847 Free PMC article.
-
Genomic profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization.PLoS One. 2013;8(2):e56165. doi: 10.1371/journal.pone.0056165. Epub 2013 Feb 14. PLoS One. 2013. PMID: 23457519 Free PMC article.
-
Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival.BMC Cancer. 2016 Mar 15;16:219. doi: 10.1186/s12885-016-2261-x. BMC Cancer. 2016. PMID: 26979459 Free PMC article.
-
Zoom-in array comparative genomic hybridization (aCGH) to detect germline rearrangements in cancer susceptibility genes.Methods Mol Biol. 2010;653:221-35. doi: 10.1007/978-1-60761-759-4_13. Methods Mol Biol. 2010. PMID: 20721746 Review.
-
The role of high-throughput technologies in clinical cancer genomics.Expert Rev Mol Diagn. 2013 Mar;13(2):167-81. doi: 10.1586/erm.13.1. Expert Rev Mol Diagn. 2013. PMID: 23477557 Review.
Cited by
-
Contralateral breast cancers: Independent cancers or metastases?Int J Cancer. 2018 Jan 15;142(2):347-356. doi: 10.1002/ijc.31051. Epub 2017 Sep 28. Int J Cancer. 2018. PMID: 28921573 Free PMC article.
-
Estimating the probability of clonal relatedness of pairs of tumors in cancer patients.Biometrics. 2018 Mar;74(1):321-330. doi: 10.1111/biom.12710. Epub 2017 May 8. Biometrics. 2018. PMID: 28482133 Free PMC article.
-
Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.PLoS One. 2015 Nov 10;10(11):e0142487. doi: 10.1371/journal.pone.0142487. eCollection 2015. PLoS One. 2015. PMID: 26554380 Free PMC article.
-
Integrative genomics with mediation analysis in a survival context.Comput Math Methods Med. 2013;2013:413783. doi: 10.1155/2013/413783. Epub 2013 Dec 18. Comput Math Methods Med. 2013. PMID: 24454535 Free PMC article.
-
Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?Breast Cancer Res Treat. 2012 Dec;136(3):693-703. doi: 10.1007/s10549-012-2290-3. Epub 2012 Oct 27. Breast Cancer Res Treat. 2012. PMID: 23104223 Free PMC article.
References
-
- Huang J, Behrens C, Wistuba I, Gazdar AF, Jagirdar J. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. Ann Diagn Pathol. 2001;5:321–329. - PubMed
-
- Dacic S, Ionescu DN, Finkelstein S, Yousem SA. Patterns of allelic loss of synchronous adenocarcinomas of the lung. Am J Surg Pathol. 2005;29:897–902. - PubMed
-
- Geurts TW, Nederlof PM, van den Brekel MW, et al. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res. 2005;11:6608–6614. - PubMed
-
- Leong PP, Rezai B, Koch WM, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst. 1998;90:972–977. - PubMed
-
- Hiroshima K, Toyozaki T, Kohno H, Ohwada H, Fujisawa T. Synchronous and metachronous lung carcinomas: molecular evidence for multicentricity. Pathol Int. 1998;48:869–876. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources